HANLY ANN M. (Chief Technology Officer) sold 10.7% of their position (14.17K shares) of VIR BIOTECHNOLOGY, INC. on the open market
Open‑market sale worth $133.9K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 2/25/2025ACC: 0001628280-25-007706
Officer· Chief Technology Officer
Since Mar 2021
-14.17K
Net shares
Net seller
$133.9K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
14.17K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−14.17K
Price / share
$9.45
Trade value
$133.94K
% of position
10.7%
2/24/2025
132.07K→117.90K
Total
Net shares
−14.17K
Net value
-$133.94K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/24/2025 | S · Sale | −14.17K | $9.45 | $133.94K | 10.7% | 132.07K | 117.90K |
| Total | −14.17K | -$133.94K | ||||||
Derivative Transactions0
No derivative transactions reported